Revisiting the Montreal Cognitive Assessment in a European cohort of elderly living with type 2 diabetes

Pharmacology, Toxicology and Pharmaceutical Science

• Non Insulin Dependent Diabetes Mellitus 100%
• Alzheimer's Disease 40%
• Cohort Study 20%
• Cognitive Defect 20%
• Prevalence 20%
• Cross-Sectional Study 20%
• Mild Cognitive Impairment 20%
• Disease Exacerbation 20%
• Multiinfarct Dementia 20%

Psychology

• Montreal Cognitive Assessment 100%
• Neuropsychological Test Battery 28%
• False-Positive Rate 28%
• Alzheimer's Disease 14%
• Cognitive Impairment 14%
• Mild Cognitive Impairment 14%

Nursing and Health Professions

• Neuropsychological Test 28%
• Clinical Dementia Rating 14%